American Lung Association Honors Dr. Tim Morris
Congratulations to Tim Fernandes! Dr. Fernandes was a semifinalist for the Top Poster Award at CHEST 2012. The title of his poster, "Hospital-acquired and Post-discharge Venous Thromboembolism (VTE) in Patients with Cancer Hospitalized for a Medical Illness: Analysis of Risk Factors and Effect on Survival." Dr. Fernandes was one of only 10 finalists for this award. The decision for the top finalist will be announced next week.
We are pleased to announce that 6 of our physicians were named “Top Docs” in San Diego Magazine’s “Physicians of Exceptional Excellence” survey. The list is created by compiling the responses of each member of the San Diego County Medical Society, who is asked to vote for board-certified physicians practicing in San Diego County to whom they would refer their own patients, family and friends. Being rated among the best by colleagues is a distinct honor. These physicians are being recognized not only for their expertise, but for their dedication to our patients and for providing superb service.
Congratulations for the recognition of your excellent work!
Congratulations to Our Health Sciences Colleagues on Their Recent Appointments, Accomplishments, Awards and Honors:
Dr. Timothy Bigby received the Department of Medicine's Leadership & Innovation in Patient-Centered Systems Award for 2011-2012. The annual award recognizes the clinical program leader whose efforts have achieved particular excellence in service of the patient care mission in internal medicine and its subspecialties.
- Congratulations to Dr. Peter Fedullo as new Chief of Staff for UCSD Medical Center. The Medical Staff Administration has appointed Dr. Fedullo to this position for 2012 - 2014. Dr. Fedullo previously served as Vice Chief of Staff from 2010 – 2012.
Congratulations to Dr. Mark Fuster for his first RO1 Grant titled, "Lymphatic Microenvironment: Altering Cell Traffic by Targeting Glycans". According to Dr. Fuster, the basic focus is on novel mechanisms that control the traffic of immune cells and tumor cells to regional lymph nodes. According to Dr. Fuster, the basic focus is on novel mechanisms that control the traffic of immune cells and tumor cells to regional lymph nodes. Understanding the mechanisms that control such "lymphatic cell traffic," including immunologic responses in cancer, is an area of opportunity. We think that the actions of some key molecules that drive such cell traffic may be "orchestrated" by novel interactions with complex carbohydrates on the lymphatic landscape. He hopes that the research will guide the development of new approaches to inhibit pathologic immune responses as well as tumor-cell traffic. Another hope is to improve our basic understanding of lymphatic vascular biology.